(3) The extent of decrease of serum hepcidin levels was also linearly associated with an improvement of quality of life in RLS patients after 12 weeks of dopaminergic treatment after adjusting for age, sex, CRP, depression, anxiety and insomnia severity. This evidence concerns the gene HAMP and insomnia measurement.